Echocardiographic Study of a Single Dose Bisoprolol Versus Nebivolol in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, crossover study in healthy adult subjects. Each subject
will receive a single dose of bisoprolol 5 mg p.o. and nebivolol 5 mg p.o. with 1 week
washout period. All subjects will undergo a physical examination, 12-lead electrocardiography
and a comprehensive echocardiographic study before the administration of the study drug and 5
hours thereafter.